Flupenthixol versus Risperidone: Subjective Quality of Life as an Important Factor for Compliance in Chronic Schizophrenic Patients

Publisher： Karger

E-ISSN： 1423-0224|47|1|37-46

ISSN： 0302-282x

Source： Neuropsychobiology, Vol.47, Iss.1, 2003-03, pp. : 37-46

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pituitary-Adrenal and Parasympathetic Function in Chronic Schizophrenic Patients with Postoperative Ileus or Hypotension

By  

Neuropsychobiology, Vol. 39, Iss. 3, 1999-04 ,pp. : 125-130

Karger

Access to resources Recommend Favorite

Increased Plasma Brain-Derived Neurotropic Factor, Not Nerve Growth Factor-Beta, in Schizophrenia Patients with Better Response to Risperidone Treatment

By  

Neuropsychobiology, Vol. 59, Iss. 1, 2009-03 ,pp. : 51-58

Karger

Access to resources Recommend Favorite

Increased Plasma Vasopressin and Atrial Natriuretic Peptide in Chronic Schizophrenic Patients during Abdominal Surgery

By  

Neuropsychobiology, Vol. 37, Iss. 4, 1998-06 ,pp. : 169-174

Karger

Access to resources Recommend Favorite

Amisulpride versus Risperidone Treatment for Behavioral and Psychological Symptoms in Patients with Dementia of the Alzheimer Type: A Randomized, Open, Prospective Study

By  

Neuropsychobiology, Vol. 54, Iss. 4, 2007-04 ,pp. : 247-251

Karger

Access to resources Recommend Favorite

Perception of Dreams and Subjective Sleep Quality in Patients with Myasthenia gravis

By  

Neuropsychobiology, Vol. 50, Iss. 1, 2004-06 ,pp. : 21-27

Karger

Access to resources Recommend Favorite